DOI: 10.1055/s-00023610

Drug Research


Kaku K, Watada H, Iwamoto Y et al., Tofogliflozin 003 Study Group.
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.

Cardiovasc Diabetol 2014;
13: 65

Download Bibliographical Data

Search in: